Yvette Drew
Impact in
- Oncology top 1%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 53
- PARP inhibition in cancer therapy 44
-
- DNA Repair Mechanisms 15
- Cell death mechanisms and regulation 5
- Co-authors
- Nicola J. Curtin (21 shared papers)Alice Bradbury (6 shared papers)Rebecca Kristeleit (11 shared papers)Jonathan A. Ledermann (4 shared papers)Ruth Plummer (16 shared papers)Zdeněk Hostomský (4 shared papers)Stuart Rundle (1 shared paper)Asima Mukhopadhyay (5 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Annals of Oncology (8 papers)Cancers (6 papers)British Journal of Cancer (6 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Yvette Drew
69 papers receiving 2.4k citations
Yvette Drew's Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 1.7k
- Reproductive Medicine 480
- Molecular Biology 1.2k
- Obstetrics and Gynecology 107
- Immunology 275
Countries citing papers authored by Yvette Drew
This map shows the geographic impact of Yvette Drew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvette Drew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvette Drew more than expected).
Fields of papers citing papers by Yvette Drew
This network shows the impact of papers produced by Yvette Drew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvette Drew. The network helps show where Yvette Drew may publish in the future.
Co-authors
The 25 scholars most cited alongside Yvette Drew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 211 | |
| 2 | 2016 | 198 | |
| 3 | 2010 | 192 | |
| 4 | 2017 | 187 | |
| 5 | 2017 | 180 | |
| 6 | 2016 | 127 | |
| 7 | 2019 | 124 | |
| 8 | 2018 | 113 | |
| 9 | 2019 | 81 | |
| 10 | 2021 | 80 | |
| 11 | DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications Hit paper breakdown → | 2024 | 72 |
| 12 | 2009 | 69 | |
| 13 | 2009 | 62 | |
| 14 | 2020 | 60 | |
| 15 | 2020 | 51 | |
| 16 | 2010 | 48 | |
| 17 | 2008 | 42 | |
| 18 | 2015 | 36 | |
| 19 | 2018 | 31 | |
| 20 | 2018 | 31 |
About Yvette Drew
Yvette Drew is a scholar working on Oncology, Molecular Biology, Reproductive Medicine, Genetics and Pulmonary and Respiratory Medicine, having authored 70 papers that have together received 2.4k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (44 papers), DNA Repair Mechanisms (15 papers), Ovarian cancer diagnosis and treatment (12 papers), BRCA gene mutations in cancer (11 papers), Cell death mechanisms and regulation (5 papers), Toxin Mechanisms and Immunotoxins (5 papers), Cancer Genomics and Diagnostics (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Oncology (1.7k citations), Reproductive Medicine (480 citations), Molecular Biology (1.2k citations), Obstetrics and Gynecology (107 citations) and Immunology (275 citations). Yvette Drew has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Nicola J. Curtin, Alice Bradbury, Rebecca Kristeleit, Jonathan A. Ledermann, Ruth Plummer, Zdeněk Hostomský, Stuart Rundle, Asima Mukhopadhyay, Richard J. Edmondson and Suzanne Kyle. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancers, British Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.